We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples from a control group for comparator purposes. In doing so, we will be able to describe the "phenotypic" expression of these diseases.
Interstitial lung disease
Does not have Interstitial lung disease
Subjects cared for in the ILD (Interstitial Lung Disease)clinic
Other
Prospective
Not listed
Natural history of course of disease in patients with Interstitial lung disease (ILD)
We assess mortality roughly yearly but duration is unlimited
Click on the lead sponsor to view all of their trials.
University of Chicago
Lead sponsor
Idiopathic Pulmonary Fibrosis Clinical Research Network
Collaborator
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator
